Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03971097 · ClinicalTrials.gov registry record · NA
The Effect of Self-Forgiveness on Self-Stigma in Addiction.
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT03971097 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 130 participants.
The verdict
NCT03971097, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
This study has an experimental design and will examine the difference in pre-test and post-test data on the Self-Forgiveness Dual Process Scale (SFDPS) (Griffin, Worthington, Davis, Hook, \& Maguen, 2018) and the Substance Abuse Self-Stigma Scale (SASSS) (Luoma et al., 2013). Data will be collected from two groups of participants receiving counseling at the short-term rehabilitation facility located at University of Pittsburgh Medical Center's (UPMC). Individuals who agree to participate in the study will be randomly assigned to either the experimental group (EG) or the control group (CG). Data collected will include pre-test SFDPS and SASSS scores for the EG and the CG (collected within 24-hours of admission), and post-test SFDPS and SASSS scores for the EG and CG (collected after 14 days). ANCOVA will be used to analyze the pre-test and post-test data recorded from participants' scores.
Interventions
- BEHAVIORAL Treatment as Usual (TAU)
- BEHAVIORAL Six Step Model of Self-Forgiveness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03971097
The ClinicalTrials.gov registry entry for NCT03971097 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.
NCT03971097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03971097 about?
NCT03971097 is a clinical study titled "The Effect of Self-Forgiveness on Self-Stigma in Addiction.". This study has an experimental design and will examine the difference in pre-test and post-test data on the Self-Forgiveness Dual Process Scale (SFDPS) (Griffin, Worthington, Davis, Hook, \& Maguen, 2018) and the Substance Abuse Self-Stigma Scale (SASSS) (Luoma et al., 2013). Data will be collected ...
What is the current status of trial NCT03971097?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2019-08-01. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03971097?
The interventions under investigation include: Treatment as Usual (TAU) (BEHAVIORAL), Six Step Model of Self-Forgiveness (BEHAVIORAL).
Who is sponsoring clinical trial NCT03971097?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.